<?xml version="1.0" encoding="UTF-8"?>
<ref id="B15-viruses-12-00926">
 <label>15.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Riber</surname>
    <given-names>C.F.</given-names>
   </name>
   <name>
    <surname>Hinton</surname>
    <given-names>T.M.</given-names>
   </name>
   <name>
    <surname>Gajda</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Zuwala</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Tolstrup</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Stewart</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Zelikin</surname>
    <given-names>A.N.</given-names>
   </name>
  </person-group>
  <article-title>Macromolecular Prodrugs of Ribavirin: Structure-Function Correlation as Inhibitors of Influenza Infectivity</article-title>
  <source>Mol. Pharm.</source>
  <year>2017</year>
  <volume>14</volume>
  <fpage>234</fpage>
  <lpage>241</lpage>
  <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.6b00826</pub-id>
  <pub-id pub-id-type="pmid">28043136</pub-id>
 </element-citation>
</ref>
